GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
Von Coelln, R, Thomas, B, Savitt, JM, Lim, KL, Sasaki, M, Hess, EJ, Dawson, VL and Dawson, TM (2004) Loss of locus coeruleus neurons and reduced startle in parkin null mice. Proc. Natl. Acad. Sci. U.S.A. 101:10744-9
Parkinson's disease (PD) is the most common neurodegenerative movement disorder and is characterized pathologically by degeneration of catecholaminergic neurons of the substantia nigra pars compacta and locus coeruleus, among other regions. Autosomal-recessive juvenile Parkinsonism (ARJP) is caused by mutations in the PARK2 gene coding for parkin and constitutes the most common familial form of PD. The majority of ARJP-associated parkin mutations are thought to be loss of function-mutations; however, the pathogenesis of ARJP remains poorly understood. Here, we report the generation of parkin null mice by targeted deletion of parkin exon 7. These mice show a loss of catecholaminergic neurons in the locus coeruleus and an accompanying loss of norepinephrine in discrete regions of the central nervous system. Moreover, there is a dramatic reduction of the norepinephrine-dependent startle response. The nigrostriatal dopaminergic system does not show any impairment. This mouse model will help gain a better understanding of parkin function and the mechanisms underlying parkin-associated PD.
Adrenergic alpha-Agonists/metabolism; Animals; Behavior, Animal/physiology; Exons; Female; Gene Deletion; Humans; Locus Coeruleus/cytology; Male; Mice; Mice, Knockout; Neurons/cytology; Neurons/metabolism; Norepinephrine/metabolism; Startle Reaction/genetics; Startle Reaction/physiology; Tyrosine 3-Monooxygenase/metabolism; Ubiquitin-Protein Ligases/genetics; Ubiquitin-Protein Ligases/metabolism
|Gene product||Qualifier||GO ID||GO term name||Evidence Code||with/from||Aspect||Notes||Status|
See Help:References for how to manage references in GONUTS.